Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Oesophageal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04138212
What this trial is testing

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 456
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Not applicableUnknownNCT04813406
What this trial is testing

Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital 53
Early research (Phase 1)Not Yet RecruitingNCT07154108
What this trial is testing

Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer

Who this might be right for
Esophageal CancerHead and Neck Cancer (H&Amp;Amp;Amp;N)
Sichuan University 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06861777
What this trial is testing

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
YIN LI 474
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Testing effectiveness (Phase 2)Study completedNCT00445861
What this trial is testing

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Early research (Phase 1)Study completedNCT01626209
What this trial is testing

A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors

Who this might be right for
Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology
Novartis Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT01129206
What this trial is testing

Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinomas of the Gastroesophageal JunctionRecurrent Esophageal Cancer+2 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Testing effectiveness (Phase 2)UnknownNCT05743504
What this trial is testing

Immunotherapy With CCRT Followed by Surgery for Locally Advanced ESCC Patients

Who this might be right for
Locally Advanced Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT07403136
What this trial is testing

Becotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 104
Testing effectiveness (Phase 2)Study completedNCT03116152
What this trial is testing

Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment

Who this might be right for
Esophageal Squamous Cell Carcinoma
Innovent Biologics (Suzhou) Co. Ltd. 190
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Large-scale testing (Phase 3)Study completedNCT03600831
What this trial is testing

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Huai'an First People's Hospital 434
Testing effectiveness (Phase 2)UnknownNCT06055153
What this trial is testing

DV Combined With PD-1 and Platinum-based First-line Treatment in Patients With HER2 IHC2+/3+ ESCC

Who this might be right for
Esophageal Squamous CarcinomaHER-2 Protein Overexpression
Changhai Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03925870
What this trial is testing

KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 45
Testing effectiveness (Phase 2)UnknownNCT04054518
What this trial is testing

Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tiago Biachi 22
Early research (Phase 1)Not Yet RecruitingNCT07034118
What this trial is testing

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

Who this might be right for
Esophageal Carcinoma
Anhui Provincial Hospital 23
Next Page